Tentamus Group today announced that it has acquired a majority stake in the leading analytical testing services company to pharmaceutical companies, Megsan Labs (in Hyderabad, India). The acquisition is part of Tentamus’ plan to broaden its portfolio of services that support pharmaceutical and biotech customers globally and expand across India with additional investments in food and agriculture services companies.

The acquisition brings complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialization. The expanded service platform will enable Tentamus Pharma to collaborate earlier with customers to support their complex drug formulations and delivery requirements as they face increasingly competitive and regulated markets.

 “We are proud and delighted to welcome the talented team of Megsan Lab and their customers to Tentamus Pharma,” commented Abgar Barseyten, Founder & CEO of Tentamus Group. “Their expertise and capabilities will deepen our current range of services offered to customers. This enables us to participate in a broader spectrum of the pre-clinical, clinical trial and market launch phases of drug development.”

Jayapal Reddy, CEO and Shareholder: “We are proud to have played a crucial role for our customers in many end-markets throughout our history. During the last 5 years, we have made substantial investments into state-of-the-art lab facilities equipped with the best-in-class instrumentation, key scientific talent and industry-leading commercial resources. We share many attributes of Tentamus’s mindset. We are confident that the business is set for a successful and exciting future under the global reach and scientific expertise of Tentamus.” In addition to this, there is no change in key managerial positions, day to day activities will be as usual.

About Megsan Labs

Megsan is a leading US-FDA approved business, which provides analytical testing services to pharmaceutical and related companies. The services comprise elemental impurity studies, E&L studies, method development & validation and microbiological testing. Jayapal Reddy and his wife Jyothirmai Reddy founded the company in 2012. Today Megsan employs more than 140 people.  For further information please visit: www.megsanlabs.com

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://tentamus.com

Ansprechpartner:
Jayapal Reddy Madireddy
CEO Megsan Labs Pvt Ltd
E-Mail: m.jayapalreddy@megsanlabs.com
Abgar Barseyten
CEO Tentamus Group GmbH
E-Mail: abgar.barseyten@tentamus.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel

Tentamus Group today announced that it has acquired a majority stake in the leading analytical testing services company to pharmaceutical companies, Megsan Labs (in Hyderabad, India). The acquisition is part of Tentamus’ plan to broaden its portfolio of services that support pharmaceutical and biotech customers globally and expand across India with additional investments in food and agriculture services companies.

The acquisition brings complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialization. The expanded service platform will enable Tentamus Pharma to collaborate earlier with customers to support their complex drug formulations and delivery requirements as they face increasingly competitive and regulated markets.

 “We are proud and delighted to welcome the talented team of Megsan Lab and their customers to Tentamus Pharma,” commented Abgar Barseyten, Founder & CEO of Tentamus Group. “Their expertise and capabilities will deepen our current range of services offered to customers. This enables us to participate in a broader spectrum of the pre-clinical, clinical trial and market launch phases of drug development.”

Jayapal Reddy, CEO and Shareholder: “We are proud to have played a crucial role for our customers in many end-markets throughout our history. During the last 5 years, we have made substantial investments into state-of-the-art lab facilities equipped with the best-in-class instrumentation, key scientific talent and industry-leading commercial resources. We share many attributes of Tentamus’s mindset. We are confident that the business is set for a successful and exciting future under the global reach and scientific expertise of Tentamus.” In addition to this, there is no change in key managerial positions, day to day activities will be as usual.

About Megsan Labs

Megsan is a leading US-FDA approved business, which provides analytical testing services to pharmaceutical and related companies. The services comprise elemental impurity studies, E&L studies, method development & validation and microbiological testing. Jayapal Reddy and his wife Jyothirmai Reddy founded the company in 2012. Today Megsan employs more than 140 people.  For further information please visit: www.megsanlabs.com

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://tentamus.com

Ansprechpartner:
Jayapal Reddy Madireddy
CEO Megsan Labs Pvt Ltd
E-Mail: m.jayapalreddy@megsanlabs.com
Abgar Barseyten
CEO Tentamus Group GmbH
E-Mail: abgar.barseyten@tentamus.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel